Search - tctmd.com

Displaying 501 - 520 of 1242

Sort: Relevancy | Date

News Daily News

Late Follow-up of Surgical MV Repair: Insights for Timing, Innovation

Shelley Wood

August 20, 2019

News Daily News

CMS Opens a Review of Coverage for Transcatheter Mitral Valve Repair

Todd Neale

August 20, 2019

News Daily News

Earlier Care, More Data Needed to Increase Treatment Success in Tricuspid Regurgitation

Yael L. Maxwell

August 07, 2019

Podcast TCTMD Talking Points

Quality of Life in the COAPT Study

July 24, 2019

News Daily News

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

Michael O'Riordan

July 17, 2019

News Industry News

Abbott Receives U.S. Approval Of Next-Generation Mitraclip™, Bringing New Enhancements To Abbott's Leading Mitraclip Platform

July 15, 2019

News Daily News

Elevated BP Linked to Risk of Valvular Heart Disease, Including Aortic Stenosis

Michael O'Riordan

July 12, 2019

News Industry News

Cardiac Dimensions Reaches 1,000 Implants Of Carillon® System, A Minimally Invasive Treatment For Functional Mitral Regurgitation

July 01, 2019

News Conference News TVT 2019

Pascal Transcatheter Device Safe, Improves Tricuspid Regurgitation: Early Results

Shelley Wood

June 19, 2019

News Conference News TVT 2019

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

Michael O'Riordan

June 19, 2019

News Conference News TVT 2019

What’s The Future For Treating Mitral Valve Disease: Repair, Replace, or Combination Approaches?

Michael O'Riordan

June 14, 2019

Presentation TVT 2019

Transcatheter Mitral Valve Repair After Transcatheter Ventricular Repair in a Patient With Severe Functional Mitral Regurgitation

Presenter: Arun Kanmanthareddy

June 14, 2019

Presentation TVT 2019

Acute Right Ventricular Reverse Remodeling Following Transcatheter Edge-To-Edge Repair of Severe Tricuspid Regurgitation

Presenter: Jeremy Ben-Shoshan

June 14, 2019

Presentation TVT 2019

Proportional vs. Disproportional Mitral Regurgitation — The New Paradigm

Presenter: Milton Packer

June 14, 2019

Presentation TVT 2019

Treatment of Functional Mitral Regurgitation by Hybrid Left Ventricular Reconstruction: Preliminary Proof of Principle

Presenter: Patrick Klein

June 13, 2019

Presentation TVT 2019

Recurrent Mitral Regurgitation Post-Transcatheter Mitral Valve Repair

Presenter: Justin Strote

June 13, 2019

Presentation TVT 2019

Distribution of Effective Regurgitant Orifice Area and Regurgitant Volume Compared to Left Ventricular End-Diastolic Volume in a Cohort of Patients With Secondary Mitral Regurgitation

Presenter: Anna Sannino

June 13, 2019

Presentation TVT 2019

6-Month Outcomes from the Multicenter, Prospective Study With the Novel PASCAL Transcatheter Mitral Repair System for Patients With Mitral Regurgitation

Presenter: Scott Lim

June 13, 2019

Presentation TVT 2019

30-Day Outcomes From an Early Feasibility Study to Assess the Safety and Effectiveness of a Novel Transfemoral TAVR System for the Treatment of Patients With Symptomatic Severe Aortic Regurgitation (AR)

Presenter: Vinod Thourani

June 13, 2019

Presentation TVT 2019

Plenary Lecture: Imaging Issues in Mitral Regurgitation and Impact on Trial Design

Presenter: Paul Grayburn

June 12, 2019

Advertisement

Late Follow-up of Surgical MV Repair: Insights for Timing, Innovation

CMS Opens a Review of Coverage for Transcatheter Mitral Valve Repair

Earlier Care, More Data Needed to Increase Treatment Success in Tricuspid Regurgitation

Quality of Life in the COAPT Study

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

Abbott Receives U.S. Approval Of Next-Generation Mitraclip™, Bringing New Enhancements To Abbott's Leading Mitraclip Platform

Elevated BP Linked to Risk of Valvular Heart Disease, Including Aortic Stenosis

Cardiac Dimensions Reaches 1,000 Implants Of Carillon® System, A Minimally Invasive Treatment For Functional Mitral Regurgitation

Pascal Transcatheter Device Safe, Improves Tricuspid Regurgitation: Early Results

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

What’s The Future For Treating Mitral Valve Disease: Repair, Replace, or Combination Approaches?

Transcatheter Mitral Valve Repair After Transcatheter Ventricular Repair in a Patient With Severe Functional Mitral Regurgitation

Acute Right Ventricular Reverse Remodeling Following Transcatheter Edge-To-Edge Repair of Severe Tricuspid Regurgitation

Proportional vs. Disproportional Mitral Regurgitation — The New Paradigm

Treatment of Functional Mitral Regurgitation by Hybrid Left Ventricular Reconstruction: Preliminary Proof of Principle

Recurrent Mitral Regurgitation Post-Transcatheter Mitral Valve Repair

Distribution of Effective Regurgitant Orifice Area and Regurgitant Volume Compared to Left Ventricular End-Diastolic Volume in a Cohort of Patients With Secondary Mitral Regurgitation

6-Month Outcomes from the Multicenter, Prospective Study With the Novel PASCAL Transcatheter Mitral Repair System for Patients With Mitral Regurgitation

30-Day Outcomes From an Early Feasibility Study to Assess the Safety and Effectiveness of a Novel Transfemoral TAVR System for the Treatment of Patients With Symptomatic Severe Aortic Regurgitation (AR)

Plenary Lecture: Imaging Issues in Mitral Regurgitation and Impact on Trial Design

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content